C223 (Alendronate Sodium 35 mg)
Pill with imprint C223 is White, Capsule-shape and has been identified as Alendronate sodium 35 mg. It is supplied by Cipla USA Inc..
Alendronate is used in the treatment of osteoporosis; prevention of osteoporosis; paget's disease; aseptic necrosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Alendronate 35 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for C223
Alendronate sodium
- Imprint:
- C223
- Strength:
- 35 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Bisphosphonates
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Cipla USA Inc.
- National Drug Code (NDC):
- 69097-0223
More about alendronate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 37 Reviews – Add your own review/rating
- Drug class: bisphosphonates
Consumer resources
- Alendronate
- Alendronate Effervescent Tablets
- Alendronate Tablets
- Alendronate Oral Solution
- Alendronate (Advanced Reading)
Other brands: Fosamax, Binosto
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
